Dual Disorder Patients: Clinical and Therapeutical Aspects - Volume Two
A special issue of Sci (ISSN 2413-4155).
Deadline for manuscript submissions: closed (20 June 2022) | Viewed by 348
Special Issue Editors
Interests: substance use disorders; psychiatric comorbidity; alcoholism; bipolar disorder; psychopharmacology
Special Issue Information
Dear Colleagues,
We are pleased to invite you to contribute to the Sci Special Issue “Dual Disorder Patients: Clinical and Therapeutical Aspects - Volume Two”. We welcome the submission of both original research and critical review articles for possible publication in the issue.
Topics of interest for this issue include:
- Predictors of substance use patterns and transition to addiction in relation to coexisting psychiatric disorders;
- Effectiveness of anticraving agents in specific dual diagnosis clinical pictures;
- Evidence of persistent psychiatric disorders induced by addictive substance use;
- Improvements in early and late attrition of dual diagnosis patients enrolled in addiction treatment programs;
- Therapies targeting psychotic symptoms of cannabis users and aggressive behavior of cannabis using patients;
- Opiate agonists and antagonists: effects of dual diagnosis and related behaviors, in a categorial or dimensional perspective.
Dr. Matteo Pacini
Dr. Angelo Giovanni Icro Maremmani
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Sci is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- dual diagnosis
- methadone, buprenorphine, naltrexone, nalmefene
- craving
- treatment retention
- behavioral outcome
- polyabuse
- methamphetamine or cathinone induced disorders
- cannabis induced disorders.
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
